Merit Medical (MMSI) Systems announced the enrollment of the first patient in the WRAP North America registry. The WRAP North America registry is designed to enroll up to 250 US and Canadian patients on hemodialysis who experience obstructions, such as stenosis or occlusion in the veins required for dialysis. The WRAPSODY CIE is designed to help clinicians restore vascular access in patients on hemodialysis who experience such obstructions. The study protocol provides for evaluation of clinical outcomes in patients treated with the WRAPSODY CIE over three years. Omar Davis, MD, President and Medical Director at Bluff City Vascular and Investigator in the WRAP North America registry, enrolled the first patient in the registry.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical Systems: Strong Performance, Strategic Growth, and Positive Outlook Justify Buy Rating
- Merit Medical launches Prelude Wave Hydrophilic Sheath Introducer
- Merit Medical Systems: Strong Performance and Strategic Growth Drive Buy Rating Despite Reimbursement Challenges
- Merit Medical’s Earnings Call Highlights Robust Growth
- Merit Medical price target lowered to $103 from $112 at Baird